Seniors’ Access to Critical Medications Act of 2024
This bill temporarily allows physicians to dispense outpatient prescription drugs and related supplies under the Medicare prescription drug benefit to patients via mail or to their caregivers without violating certain prohibitions under the Stark law (i.e., the Physician Self-Referral Law), if certain conditions are met. It also allows for coverage of certain external infusion pumps and associated home infusion drugs under Medicare.
Current law requires physicians to dispense outpatient prescription drugs and related supplies to patients in their office buildings in order to qualify for an exception (the in-office ancillary services exception) under the Stark law. The bill specifies that, from January 1, 2025 to December 31, 2029, physicians may dispense outpatient prescription drugs and related supplies to their patients via mail, and individuals or their family members or caregivers may pick up such items at the physician's office building, if the individual (1) had a face-to-face visit with the prescriber in the prior year, not including telehealth visits; (2) the prescriber furnished other items or services to the individual in the prior year; and (3) the prescriber has an ongoing professional relationship with the individual.
In addition, the bill specifies that external infusion pumps and associated home infusion drugs may be covered under Medicare even if they don't meet certain regulatory requirements, if these items are provided in accordance with the bill's specified criteria, including that the drug is administered under the supervision of a qualified home infusion therapy supplier.
[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5526 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 5526
To amend title XVIII of the Social Security Act to clarify the
application of the in-office ancillary services exception to the
physician self-referral prohibition for drugs furnished under the
Medicare program.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 18, 2023
Mrs. Harshbarger (for herself, Ms. Wasserman Schultz, Mr. Fleischmann,
Mr. Davis of North Carolina, Mrs. Miller-Meeks, and Mr. Balderson)
introduced the following bill; which was referred to the Committee on
Energy and Commerce, and in addition to the Committee on Ways and
Means, for a period to be subsequently determined by the Speaker, in
each case for consideration of such provisions as fall within the
jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to clarify the
application of the in-office ancillary services exception to the
physician self-referral prohibition for drugs furnished under the
Medicare program.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Seniors' Access to Critical
Medications Act of 2023''.
SEC. 2. CLARIFYING THE APPLICATION OF THE IN-OFFICE ANCILLARY SERVICES
EXCEPTION TO THE PHYSICIAN SELF-REFERRAL PROHIBITION FOR
DRUGS FURNISHED UNDER THE MEDICARE PROGRAM.
(a) In General.--Section 1877(b)(2) of the Social Security Act (42
U.S.C. 1395nn(b)(2)) is amended by adding at the end the following new
sentence: ``With respect to services consisting of drugs, and any
supplies necessary to administer such drugs, furnished on or after May
11, 2023, the requirement that such drugs and supplies be furnished in
accordance with subparagraph (A)(ii) in order to qualify as a case
described in this paragraph shall not apply.''.
(b) Withdrawal of FAQs.--The Secretary of Health and Human Services
shall remove the frequently asked questions and answers published on
the website of the Centers for Medicare & Medicaid Services on
September 20, 2021, and May 19, 2023, which prohibit or seek to
prohibit the arrangement described in the amendment made by subsection
(a) and those frequently asked questions and answers shall be deemed to
have never been published.
<all>
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 19 - 6.
Committee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 41 - 0.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-691, Part I.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-691, Part I.
Committee on Ways and Means discharged.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
Committee on Ways and Means discharged.
Placed on the Union Calendar, Calendar No. 585.
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5587-5588)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5526.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)
Motion to reconsider laid on the table Agreed to without objection.
The title of the measure was amended. Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.